Search for Clinical Trial Results

Sponsored By

Hypophosphatemia - 14 Studies Found

Status Study
Active, not recruiting Study Name: Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
Condition:
  • Hypophosphatemia
  • Renal Transplant

Date: 2009-11-09
Interventions:
  • Drug: Cinacalcet cinacalcet, 3
Completed Study Name: FGF-23 Suppressibility by Calcitonin
Condition: Hypophosphatemia
Date: 2008-05-28
Interventions:
  • Drug: Calcitonin Calcitonin 20
Completed Study Name: Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
Condition: Hypophosphatemia
Date: 2012-08-05
Terminated Study Name: Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.
Condition: Carcinoma, Renal Cell
Date: 2008-02-13
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) Sorafenib will be administered at 400mg BID for a 28 day cycle.
Terminated Study Name: Investigating a New Way of Giving Medicine to Newborn and Preterm Babies
Condition:
  • Hypophosphataemia
  • Osteopenia of Prematurity

Date: 2012-08-23
Interventions:
  • Drug: Oral thin film therapy (Potassium acid phosphate oral thin films)

Terminated Study Name: Hypophosphatemia With Intravenous Ferric Carboxymaltose Versus Iron Dextran in Women With Iron Deficiency Secondary to Heavy Uterine Bleeding
Condition: Iron Deficiency Anemia
Date: 2010-10-04
Interventions:
  • Drug: Ferric Carboxymaltose (FCM)

Completed Study Name: Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4
Condition: Chronic Kidney Disease
Date: 2008-10-01
Interventions:
  • Other: grain (soy) protein diet

Recruiting Study Name: Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition:
Date: 2026-01-10
Completed Study Name: A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
Condition:
Date: 2026-01-10
Active, not recruiting Study Name: Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Condition:
Date: 2026-01-10
Next >>>